Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M597Revenue $M13.7Net Margin (%)-705.5Altman Z-Score-3.5
Enterprise Value $M533EPS $-1.2Operating Margin %-551.7Piotroski F-Score4
P/E(ttm)--Beneish M-Score3.8Pre-tax Margin (%)-705.0Higher ROA y-yY
Price/Book12.110-y EBITDA Growth Rate %--Quick Ratio2.5Cash flow > EarningsY
Price/Sales30.55-y EBITDA Growth Rate %29.5Current Ratio3.1Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-66.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-119.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M106ROIC % (ttm)-606.4Gross Margin Increase y-yY

Gurus Latest Trades with KERX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
KERXSeth Klarman 2015-06-30 Add0.57%$9.32 - $12.73
($10.75)
$ 5.64-48%Add 15.24%25,791,678
KERXSeth Klarman 2015-03-31 Add0.88%$10.87 - $14.68
($12.86)
$ 5.64-56%Add 22.30%22,380,200
KERXSeth Klarman 2014-09-30 Add1.87%$12.71 - $18.19
($15.32)
$ 5.64-63%Add 73.62%18,300,000
KERXSeth Klarman 2014-06-30 Add1.04%$12.11 - $17.03
($14.16)
$ 5.64-60%Add 67.01%10,539,986
KERXSeth Klarman 2014-03-31 Buy 2.6%$12.16 - $16.88
($14.98)
$ 5.64-62%New holding6,310,850
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

KERX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


KERX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Neylan John F.Chief Medical Officer 2016-04-25Sell4,766$5.2114.4view
Adams BrianVP and General Counsel 2016-04-15Sell1,060$5.0518.02view
Madison GregPresident and CEO 2016-04-05Sell1,078$4.532.44view
Adams BrianVP and General Counsel 2016-04-05Sell759$4.532.44view
Madison GregPresident and CEO 2016-02-09Sell1,938$3.2384.52view
Adams BrianVP and General Counsel 2016-01-15Sell1,322$3.380.61view
Adams BrianVP and General Counsel 2016-01-06Sell3,004$5.1615.5view
Madison GregPresident and CEO 2016-01-06Sell4,261$4.8323.4view
Adams BrianVP and General Counsel 2016-01-06Sell3,004$4.8323.4view
Madison GregPresident and CEO 2015-11-09Sell1,638$5.1815.06view

Quarterly/Annual Reports about KERX:

News about KERX:

Articles On GuruFocus.com
Klarman Gives Insight on Keryx Biopharmaceuticals Investment Jan 26 2016 
Seth Klarman Blames Market, Investments for Rare Down Year Jan 25 2016 
David Abrams Buys Stake in Heavy Equipment Company Dec 15 2015 
Why Seth Klarman Keeps Buying Keryx Biopharma Nov 03 2015 
Seth Klarman Raises Position in Keryx Biopharmaceuticals Oct 21 2015 
Seth Klarman Buys Pharmaceutical Company's Shares to Fund Drug Launch Oct 12 2015 
Is Seth Klarman right about Keryx Inc.? Jun 25 2015 
Seth Klarman Buys Pioneer Natural Resources, SunEdison Semiconductor Ltd, Atara Biotherapeutics Inc, May 15 2015 
Analysts Positive on Keryx Biopharmaceuticals, Inc. Despite Weak Prescription Data May 05 2015 
Roth Capital Weighs In On 5 Biotech Stocks to Watch Apr 05 2015 

More From Other Websites
Keryx (KERX) Q1 Loss in Line, Auryxia Up on Strong Demand (Revised) Apr 29 2016
Edited Transcript of KERX earnings conference call or presentation 28-Apr-16 12:00pm GMT Apr 28 2016
Keryx Biopharma reports 1Q loss Apr 28 2016
Keryx Biopharma reports 1Q loss Apr 28 2016
Keryx Biopharmaceuticals Inc Earnings Call scheduled for 8:00 am ET today Apr 28 2016
Keryx (KERX) Reports Wider-Than-Expected Loss in Q1 Apr 28 2016
KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Apr 28 2016
Keryx Biopharmaceuticals Announces First Quarter 2016 Financial Results Apr 28 2016
Q1 2016 Keryx Biopharmaceuticals Inc Earnings Release - Before Market Open Apr 28 2016
Keryx Biopharmaceuticals Announces First Quarter 2016 Financial Results Apr 28 2016
Drug Stocks' Earnings Previews: KERX, BXLT, BMRN, AGEN, IMGN Apr 27 2016
What's in Store for Keryx (KERX) this Earnings Season? Apr 25 2016
Keryx Biopharmaceuticals to Host Conference Call of First Quarter 2016 Financial Results on... Apr 14 2016
Keryx Biopharmaceuticals to Host Conference Call of First Quarter 2016 Financial Results on... Apr 14 2016
Keryx Biopharmaceuticals Announces New Appointments and Changes to its Board of Directors Apr 01 2016
KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers,... Apr 01 2016
Keryx Biopharmaceuticals Announces New Appointments and Changes to its Board of Directors Apr 01 2016
Keryx Up on Positive Auryxia Data in Iron Deficiency Anemia Mar 30 2016
Is Propanc Health Group the Next Breakthrough Biotech Company Mar 30 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)